Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Panacea Biotec

BSE: 531349|NSE: PANACEABIO|ISIN: INE922B01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 27, 16:01
130.95
-2.35 (-1.76%)
VOLUME 5,417
LIVE
NSE
Jun 27, 15:41
131.50
-3.3 (-2.45%)
VOLUME 36,007
Announcements on Panacea Biotec

1st-Jun-2017 14:47Source: NSE

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding Corrigendum to Audited Financial Results (Standalone and consolidated) for the quarter / year ended 31 March 2017

1st-Jun-2017 14:18Source: BSE

Panacea Biotec- Updates

Corrigendum of Audited Financial Results (Standalone and consolidated) for the quarter / year ended 31st March, 2017.

30th-May-2017 20:00Source: BSE

Panacea Biotec- Financial Results For March 31, 2017

Audited Financial Results (Standalone and Consolidated) for the Quarter / Year ended 31st March, 2017

Passing over of Dividend for the financial year 2016-17

22nd-May-2017 18:15Source: BSE

Panacea Biotec- May 30,2017

Intimation of postponement of Board Meeting for approving the Audited Financial Results For the Quarter/ Financial Year ended 31st March, 2017

16th-May-2017 09:08Source: BSE

Panacea Biotec- Board Meeting On 26Th May, 2017

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 {''SEBI (LODR) Regulations''}, this is to inform you that a Meeting of the Board of Directors ...

16th-May-2017 09:04Source: BSE

Panacea Biotec- Closure of Trading Window

Pursuant to the provisions of Regulations 30 & 51 of the SEBI (LODR) Regulations, the trading window of the Company shall remain closed for all designated persons including promoters, directors, key m...

24th-Apr-2017 13:06Source: BSE

Panacea Biotec- Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 For Half-Year Ended 31St March, 2017

Pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certified copy of certificate from M/s R & D, C...

22nd-Apr-2017 16:21Source: BSE

Panacea Biotec- Compliance Certificate For The Half Year Ended 31St March, 2017.

Pursuant to the provisions of Regulation 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate duly signed by Skyline Financial Serv...

22nd-Apr-2017 11:03Source: BSE

Panacea Biotec- Shareholding for the Period Ended March 31, 2017

Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly

21st-Apr-2017 17:46Source: BSE

Panacea Biotec- Statement Of The Investor Complaints For The Quarter Ended 31St March, 2017

Pursuant to regulation 13(3) of SEBI (LODR) Regulations, 2015, statement of the Investor Complaints for the quarter ended 31st March, 2017

1 2 3 4 5 Next >>
Quick Links for Panacea Biotec
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.